Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S5 from Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial
  1. Home
  2. Publications
  3. Supplementary Figure S5 from Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial

Supplementary Figure S5 from Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial

Authors:
  • YCYihebali Chi
    Yihebali Chi
  • XZXiangqian Zheng
    Xiangqian Zheng
  • YZYuan Zhang
    Yuan Zhang
  • FSFeng Shi
    Feng Shi
  • YCYing Cheng
    Ying Cheng
  • ZGZhuming Guo
    Zhuming Guo
  • MGMinghua Ge
    Minghua Ge
  • JQJianwu Qin
    Jianwu Qin
  • JZJiewu Zhang
    Jiewu Zhang
  • ZLZhendong Li
    Zhendong Li
  • XZXiaohong Zhou
    Xiaohong Zhou
  • RHRui Huang
    Rui Huang

Open Access
Publisher website
Google Scholar
  • 25 November 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.30710290
Abstract
Best changes in the sum of longest diameters of target lesions for the anlotinib group and the placebo group. Purplish red: confirmed partial response; blue: stable disease lasting at least 4 week.
Keywords
  • CARCINOMA IN SITU
  • CLINICAL TRIAL RESULTS
  • PHASE II CLINICAL TRIALS
  • HEAD, NECK & ORAL CANCERS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.